ProCE Banner Events

Share

Team Trivia! Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis

Join top dermatology experts at a live symposium on March 9 in Orlando, where cutting-edge insights on atopic dermatitis will be delivered through expert panels, real-time case discussions, and interactive case management voting via iPads. Earn your spot on the leaderboard in this fast-paced, team competition and enhance your clinical practice with the latest advancements in patient care.  Join in-person or virtually. Complimentary dinner and drinks for in-person attendees.

Who Should Attend

This education is intended for dermatologists, allergist/immunologists, and nurse practitioners (NPs) and physician associates (PAs) practicing in dermatology and allergy who manage patients with moderate to severe atopic dermatitis.

Time and location

Sunday, March 09, 2025

7:00 PM - 9:00 PM Eastern Time (ET)

In-person

7:30 PM - 9:00 PM Eastern Time (ET)

Virtual

Hilton Orlando
6001 Destination Parkway
Orlando, Florida 32819

United States of America

Orange Ballroom E and F

Agenda

Introductions, Game Instructions

Round 1: “Pathophyz” Quiz: Exploring the Role of IL-13 in Atopic Dermatitis

Round 2: Mastering the Evidence for IL-13 Inhibition in Moderate to Severe Atopic Dermatitis

Round 3: IL-13 Inhibitors in Practice: Patient Candidacy and Treatment Advancement Strategies

Final Leaderboard Standings, Key Clinical Takeaways, Q&A

Location

Venue Name

Hilton Orlando

Address

Hilton Orlando
6001 Destination Parkway
Orlando, Florida 32819

United States of America

Room Name

Orange Ballroom E and F

CME/CE Info

This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee.

This program does not qualify for Continuing Medical Education (CME) Credit.

Goal Statement
The goal of this educational activity is to improve learners’ knowledge, competence, and performance managing advanced therapy for patients with moderate to severe atopic dermatitis.

Target Audience
This education is intended for dermatologists, allergist/immunologists, and nurse practitioners (NPs) and physician associates (PAs) practicing in dermatology and allergy who manage patients with moderate to severe atopic dermatitis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Understand the pathophysiologic contributions of IL-13 in promoting the clinical manifestations of moderate to severe AD

  • Evaluate available evidence and current guidelines to differentiate advanced therapies targeting IL-13 in moderate to severe AD

  • Assess patient candidacy for advanced biologic therapies targeting IL-13 in moderate to severe AD

Accreditation

This educational activity is not certified for CME/CE credit.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association

This activity is supported by an educational grant from Lilly.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.